Synfacts 2023; 19(10): 1037
DOI: 10.1055/s-0042-1752791
Innovative Drug Discovery and Development

Identifying the Risk of Formation of Nitrosamines and Other Potentially Mutagenic Impurities during API Manufacture Using In Silico Risk Assessment

Rezensent(en):
Antonia F. Stepan (Roche)
,
Jacob W. Greenwood (MSD)


Publikationsverlauf

Artikel online veröffentlicht:
14. September 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany